Login to Your Account



AmVac, Icon Genetics Team on Plant-Based Influenza Vaccine

By Cormac Sheridan


Wednesday, June 18, 2008
Swiss vaccine developer AmVac AG is teaming up with Bayer AG subsidiary Icon Genetics GmbH to develop a plant-based production system for making an adjuvanted influenza vaccine. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription